HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    
Learn more
Self Investors Wanted Today

Few spots available. Master Zacks' market-tripling Stock Picking Method in your home at our cost.
Opportunity ends Saturday, Nov. 21 >>

Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


SCR: Simcere Pharmaceutical Group - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
SIMCERE PHARMACEUTICAL GROUP (NYSE)
SCR 7.23 -0.03 (-0.41%) Vol.  222,305 16.00 CST

Nov 16, 2009 Simcere Pharmaceutical Group posts net income of CNY16.4m for Q3
Nov 16, 2009 Conference Calls Today: 7-8 A.M. EST
Nov 16, 2009 Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2009 Results
Nov 11, 2009 BUYINS.NET: SINA, PSUN, SCR Expected To Be Higher After Earnings Releases on Monday
Nov 10, 2009 Simcere controls Yanshen to enter into China's vaccine market
Nov 09, 2009 SCR: To Acquire Manufacturing License in China for Rosuvastatin (Crestor)
Nov 09, 2009 Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin
Nov 02, 2009 Simcere Pharmaceutical Group to Announce 2009 Third Quarter Earnings on Monday, November 16, 2009
Oct 31, 2009 United States : Simcere Pharmaceutical Group Enters Agreement to Acquire a 74.49% stake in ChinaVax
Oct 29, 2009 China : Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
Oct 29, 2009 Simcere Pharmaceutical Group to Acquire Additional Stake in Jiangsu Yanshen Biological Technology Stock Co., Ltd.
Oct 20, 2009 Groundbreaking Agreement Brings OSI-930 to China
Oct 20, 2009 Crown Equity Holdings, Inc.: CRWENews Highlights: SCR, GE
Oct 20, 2009 SCR: Collaboration w/OSI Pharmaceuticals for OSI-930 in China
Oct 20, 2009 Analyst Upgrades for October 20th
 
ZACKS COMMENTARY FOR SCR
Nov 16, 2009 Zacks Equity Research: Report for SCR
Oct 02, 2009 Zacks Blog: Simcere’s MACD Indicates Bearishness
Nov 25, 2008 Value: Simcere Pharmaceutical Group

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research